Testimonial of OncoDNA’s Journey through its founder’s words

Dive Deep into OncoDNA’s journey tells by its founder Jean-Pol Detiffe !


In this video interview, you’ll discover the inspiration behind OncoDNA’s tests and its pioneering decentralized solution: OncoDEEP Kit.

But that’s not all! Jean-Pol also underscores the significance of integrated tools specifically designed for laboratory requirements, based on more than 10 years of scientific experience and users’ feedback.

🔍 Enjoy the exploration and don’t hesitate to navigate through other sections of the portal to discover a treasure trove of cutting-edge scientific content ! 📚


We know what is important to be relevant in our report for the oncologist. All this experience is included in the kit : the database, the interpretation software, a nice chemistry to run in the lab, and it's for sure cost-effective and evolutive
Jean-Pol Detiffe
Founder of OncoDNA

You may also be interested in these resources

Scientific Application Note

PANCREATIC CANCER: Addition of a PARP inhibitor (veliparib) to gemcitabine + cisplatin chemo did not improve outcomes for patients harbouring germline mutations in BRCA1/2 or PALB2

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation Journal of Clinical Oncology May 01, 2020 ABSTRACT PURPOSEFive percent to 9% of pancreatic ductal...

Scientific Application Note

Cancer Management: Breast Cancer

5 min reading

What is Breast Cancer? With an estimated 2.26 million new cancer cases and 685 000 deaths in women, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death in 2020,...

Share This